Nano-based eye drop: Topical and noninvasive therapy for ocular diseases

C Wang, Y Pang - Advanced drug delivery reviews, 2023 - Elsevier
Eye drops are the most accessible therapy for ocular diseases, while inevitably suffering
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …

[HTML][HTML] Current trends in pharmaceutical treatment of dry eye disease: A review

HB Mohamed, BN Abd El-Hamid, D Fathalla… - European Journal of …, 2022 - Elsevier
Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

BCLA CLEAR-Contact lens complications

F Stapleton, M Bakkar, N Carnt, R Chalmers… - Contact Lens and …, 2021 - Elsevier
Contact lens-related complications are common, affecting around one third of wearers,
although most are mild and easily managed. Contact lenses have well-defined anatomical …

[HTML][HTML] Oxidative stress in the eye and its role in the pathophysiology of ocular diseases

EW Böhm, F Buonfiglio, AM Voigt, P Bachmann, T Safi… - Redox Biology, 2023 - Elsevier
Oxidative stress occurs through an imbalance between the generation of reactive oxygen
species (ROS) and the antioxidant defense mechanisms of cells. The eye is particularly …

Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy

J Wei, J Mu, Y Tang, D Qin, J Duan, A Wu - Journal of nanobiotechnology, 2023 - Springer
Ophthalmic inflammatory diseases, including conjunctivitis, keratitis, uveitis, scleritis, and
related conditions, pose considerable challenges to effective management and treatment …

Video display terminal use and dry eye: preventive measures and future perspectives

B Kamøy, M Magno, ST Nøland, MC Moe… - Acta …, 2022 - Wiley Online Library
Background Dry eye disease (DED) is a common cause of ocular pain and discomfort. Dry
eye disease (DED) stems from a loss‐of‐tear film homeostasis and is frequently seen in …

Dry eye syndrome: comprehensive etiologies and recent clinical trials

R Huang, C Su, L Fang, J Lu, J Chen… - International …, 2022 - Springer
Dry eye syndrome (DES) is multifactorial and likely to be a cause of concern more so than
ever given the rapid pace of modernization, which is directly associated with many of the …

Best practices in the clinical management of progressive supranuclear palsy and corticobasal syndrome: a consensus statement of the CurePSP Centers of Care

B Bluett, AY Pantelyat, I Litvan, F Ali… - Frontiers in …, 2021 - frontiersin.org
Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS; the most common
phenotype of corticobasal degeneration) are tauopathies with a relentless course, usually …

Topical ocular drug delivery systems: Innovations for an unmet need

Y Yang, A Lockwood - Experimental Eye Research, 2022 - Elsevier
The eye is an isolated and complex organ, with multiple robust anatomical and physiological
barriers on the ocular surface which protect it from noxious insults such as the blink reflex …

ONSET-1 phase 2b randomized trial to evaluate the safety and efficacy of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease

D Wirta, GL Torkildsen, B Boehmer, DA Hollander… - Cornea, 2022 - journals.lww.com
Purpose: The purpose of this trial was to evaluate the safety and efficacy of OC-01
(varenicline solution), a nicotinic acetylcholine receptor agonist nasal spray, on signs and …